Skip to main content

[vc_row][vc_column][vc_column_text css=""] The National Foundation for Cancer Research (NFCR) answers some of the most frequently asked questions about biosimilar drugs for cancer treatment. Biologic drugs (biologics) are a special class of medications that are made from living organisms, such as proteins.1 Vaccines, hormones, and anti-allergy medications are...

[vc_row][vc_column][vc_column_text] Stay Strong, Be Positive [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width="1/4"][vc_single_image image="64177" img_size="large"][/vc_column][vc_column width="3/4"][vc_column_text]Sometimes life gets busy and all you can do is put your head down and focus. That was what the autumn of 2017 looked like for Brianne Jaeger. She was a busy mother of two in her mid-thirties...

[vc_row][vc_column][vc_single_image image="39583" img_size="full" alignment="center" css=""][vc_column_text css=""]Buried amongst the pandemic commotion was the American Cancer Society’s newest cervical cancer screening guidelines. Cervical cancer affects women of all ages worldwide and is often dubbed ‘the silent killer’ as it presents with no symptoms in the early stages....

[vc_row][vc_column][vc_column_text css=""] New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology...